Fibrinogen receptor antagonists

Details Fibrinogen receptor antagonists Fibrinogen receptor antagonists

1992-03-25

1993-11-23

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 18, 530330, 530331, 530332, 546201, 548465, A61K 3702, C07K 502, C07K 506, C07K 508

Patent

active

052644200

ABSTRACT:
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

REFERENCES:
patent: 4122255 (1978-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozic
patent: 4772585 (1988-09-01), Sarnoff et al.
patent: 4871842 (1989-10-01), Sugihara et al.
patent: 4929602 (1990-05-01), Harker et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 5030654 (1991-07-01), Barnish

Affiliated with

Also associated with

Rating

Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1848957